The DOI matches its Crossref record; 106 of the 106 references it cites were found in a registry or an index.
PPARgamma agonists in the treatment of type II diabetes: is increased fatness commensurate with long-term efficacy?
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor
Tontonoz, P., Hu, E., & Spiegelman, B. M. (1994) · Cell · doi:10.1016/0092-8674(94)90006-x · Cited by 3,529
Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators
Issemann, I., & Green, S. (1990) · Nature · doi:10.1038/347645a0 · Cited by 3,519
Peroxisome Proliferator-Activated Receptors: Nuclear Control of Metabolism*
Desvergne, B., & Wahli, W. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.5.0380 · Cited by 3,086
15-Deoxy-Δ12,14-Prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ
Forman, B. M., Tontonoz, P., Chen, J., Brun, R. P., Spiegelman, B. M., & Evans, R. M. (1995) · Cell · doi:10.1016/0092-8674(95)90193-0 · Cited by 2,858
Kliewer, S. A., Sundseth, S. S., Jones, S. A., Brown, P. J., Wisely, G. B., Koble, C. S., Devchand, P., Wahli, W., Willson, T. M., Lenhard, J. M., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.9.4318 · Cited by 2,164
PPARγ Is Required for the Differentiation of Adipose Tissue In Vivo and In Vitro
Rosen, E. D., Sarraf, P., Troy, A. E., Bradwin, G., Moore, K., Milstone, D. S., Spiegelman, B. M., & Mortensen, R. M. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80211-7 · Cited by 2,079
Kliewer, S. A., Lenhard, J. M., Willson, T. M., Patel, I., Morris, D. C., & Lehmann, J. M. (1995) · Cell · doi:10.1016/0092-8674(95)90194-9 · Cited by 2,028
PPARγ Is Required for Placental, Cardiac, and Adipose Tissue Development
Barak, Y., Nelson, M. C., Ong, E. S., Jones, Y. Z., Ruiz-Lozano, P., Chien, K. R., Koder, A., & Evans, R. M. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80209-9 · Cited by 1,956
Oxidized LDL Regulates Macrophage Gene Expression through Ligand Activation of PPARγ
Nagy, L., Tontonoz, P., Alvarez, J. G. A., Chen, H., & Evans, R. M. (1998) · Cell · doi:10.1016/s0092-8674(00)81574-3 · Cited by 1,860
The common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes
Altshuler, D., Hirschhorn, J. N., Klannemark, M., Lindgren, C. M., Vohl, M.-C., Nemesh, J., Lane, C. R., Schaffner, S. F., Bolk, S., Brewer, C., et al. (2000) · Nature Genetics · doi:10.1038/79216 · Cited by 1,766
Role of Fatty Acids in the Pathogenesis of Insulin Resistance and NIDDM
Boden, G. (1997) · Diabetes · doi:10.2337/diab.46.1.3 · Cited by 1,728
Barroso, I., Gurnell, M., Crowley, V. E. F., Agostini, M., Schwabe, J. W., Soos, M. A., Maslen, G. L., Williams, T. D. M., Lewis, H., Schafer, A. J., et al. (1999) · Nature · doi:10.1038/47254 · Cited by 1,368
PPARγ Mediates High-Fat Diet–Induced Adipocyte Hypertrophy and Insulin Resistance
Kubota, N., Terauchi, Y., Miki, H., Tamemoto, H., Yamauchi, T., Komeda, K., Satoh, S., Nakano, R., Ishii, C., Sugiyama, T., et al. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80210-5 · Cited by 1,342
Deeb, S. S., Fajas, L., Nemoto, M., Pihlajamäki, J., Mykkänen, L., Kuusisto, J., Laakso, M., Fujimoto, W., & Auwerx, J. (1998) · Nature Genetics · doi:10.1038/3099 · Cited by 1,319
Inhibition of Adipogenesis Through MAP Kinase-Mediated Phosphorylation of PPARγ
Hu, E., Kim, J. B., Sarraf, P., & Spiegelman, B. M. (1996) · Science · doi:10.1126/science.274.5295.2100 · Cited by 1,050
Oliver, W. R., Shenk, J. L., Snaith, M. R., Russell, C. S., Plunket, K. D., Bodkin, N. L., Lewis, M. C., Winegar, D. A., Sznaidman, M. L., Lambert, M. H., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091021198 · Cited by 1,046
Okuno, A., Tamemoto, H., Tobe, K., Ueki, K., Mori, Y., Iwamoto, K., Umesono, K., Akanuma, Y., Fujiwara, T., Horikoshi, H., et al. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1235 · Cited by 995
Drug Treatment of Lipid Disorders
Knopp, R. H. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908123410707 · Cited by 845
Vidal-Puig, A. J., Considine, R. V., Jimenez-Liñan, M., Werman, A., Pories, W. J., Caro, J. F., & Flier, J. S. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119424 · Cited by 786
The perils of portliness: causes and consequences of visceral adiposity.
Montague, C. T., & O'Rahilly, S. (2000) · Diabetes · doi:10.2337/diabetes.49.6.883 · Cited by 737
Auboeuf, D., Rieusset, J., Fajas, L., Vallier, P., Frering, V., Riou, J. P., Staels, B., Auwerx, J., Laville, M., & Vidal, H. (1997) · Diabetes · doi:10.2337/diab.46.8.1319 · Cited by 697
ADD1/SREBP1 activates PPARγ through the production of endogenous ligand
Kim, J. B., Wright, H. M., Wright, M., & Spiegelman, B. M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.8.4333 · Cited by 669
Hu, E., Tontonoz, P., & Spiegelman, B. M. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.21.9856 · Cited by 656
Regulation of PPAR gamma gene expression by nutrition and obesity in rodents.
Vidal-Puig, A., Jimenez-Liñan, M., Lowell, B. B., Hamann, A., Hu, E., Spiegelman, B., Flier, J. S., & Moller, D. E. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118703 · Cited by 655
Yamauchi, T., Kamon, J., Waki, H., Murakami, K., Motojima, K., Komeda, K., Ide, T., Kubota, N., Terauchi, Y., Tobe, K., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103241200 · Cited by 637
Peters, J. M., Lee, S. S. T., Li, W., Ward, J. M., Gavrilova, O., Everett, C., Reitman, M. L., Hudson, L. D., & Gonzalez, F. J. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.14.5119-5128.2000 · Cited by 633
Peroxisome Proliferator–Activated Receptor γ and Metabolic Disease
Willson, T. M., Lambert, M. H., & Kliewer, S. A. (2001) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.70.1.341 · Cited by 582
Adams, M., Reginato, M. J., Shao, D., Lazar, M. A., & Chatterjee, V. K. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.8.5128 · Cited by 549
Obesity Associated with a Mutation in a Genetic Regulator of Adipocyte Differentiation
Ristow, M., Müller-Wieland, D., Pfeiffer, A., Krone, W., & Kahn, C. R. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810013391403 · Cited by 545
Adams, M., Montague, C. T., Prins, J. B., Holder, J. C., Smith, S. A., Sanders, L., Digby, J. E., Sewter, C. P., Lazar, M. A., Chatterjee, V. K., et al. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119870 · Cited by 517
Failure of adipocyte differentiation causes type II diabetes mellitus?
Danforth, E. (2000) · Nature Genetics · doi:10.1038/79111 · Cited by 487
Camp, H. S., & Tafuri, S. R. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.16.10811 · Cited by 446
Diseases of liporegulation: new perspective on obesity and related disorders
UNGER, R. H., & ORCI, L. (2001) · The FASEB Journal · doi:10.1096/fj.00-0590 · Cited by 430
Mukherjee, R., Jow, L., Croston, G. E., & Paterniti, J. R. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.12.8071 · Cited by 420
Improved insulin-sensitivity in mice heterozygous for PPAR-γ deficiency
Miles, P. D. G., Barak, Y., He, W., Evans, R. M., & Olefsky, J. M. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8538 · Cited by 400
Wright, H. M., Clish, C. B., Mikami, T., Hauser, S., Yanagi, K., Hiramatsu, R., Serhan, C. N., & Spiegelman, B. M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.3.1873 · Cited by 368
Distinct Transcriptional Profiles of Adipogenesisin Vivo and in Vitro
Soukas, A., Socci, N. D., Saatkamp, B. D., Novelli, S., & Friedman, J. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104421200 · Cited by 368
Hauser, S., Adelmant, G., Sarraf, P., Wright, H. M., Mueller, E., & Spiegelman, B. M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001297200 · Cited by 367
Depot-Specific Differences in Adipose Tissue Gene Expression in Lean and Obese Subjects
Lefebvre, A.-M., Laville, M., Vega, N., Riou, J. P., Gaal, L. V., Auwerx, J., & Vidal, H. (1998) · Diabetes · doi:10.2337/diab.47.1.98 · Cited by 366
Ren, D., Collingwood, T. N., Rebar, E. J., Wolffe, A. P., & Camp, H. S. (2002) · Genes & Development · doi:10.1101/gad.953802 · Cited by 362
Chao, L., Marcus-Samuels, B., Mason, M. M., Moitra, J., Vinson, C., Arioglu, E., Gavrilova, O., & Reitman, M. L. (2000) · Journal of Clinical Investigation · doi:10.1172/jci11245 · Cited by 356
de Souza, C. J., Eckhardt, M., Gagen, K., Dong, M., Chen, W., Laurent, D., & Burkey, B. F. (2001) · Diabetes · doi:10.2337/diabetes.50.8.1863 · Cited by 350
Way, J. M., Harrington, W. W., Brown, K. K., Gottschalk, W. K., Sundseth, S. S., Mansfield, T. A., Ramachandran, R. K., Willson, T. M., & Kliewer, S. A. (2001) · Endocrinology · doi:10.1210/endo.142.3.8037 · Cited by 338
Troglitazone action is independent of adipose tissue.
Burant, C. F., Sreenan, S., Hirano, K., Tai, T. A., Lohmiller, J., Lukens, J., Davidson, N. O., Ross, S., & Graves, R. A. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119839 · Cited by 334
A peroxisome proliferator-activated receptor γ ligand inhibits adipocyte differentiation
Oberfield, J. L., Collins, J. L., Holmes, C. P., Goreham, D. M., Cooper, J. P., Cobb, J. E., Lenhard, J. M., Hull-Ryde, E. A., Mohr, C. P., Blanchard, S. G., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.11.6102 · Cited by 316
Kelly, I. E., Han, T. S., Walsh, K., & Lean, M. E. (1999) · Diabetes Care · doi:10.2337/diacare.22.2.288 · Cited by 315
Morrison, R. F., & Farmer, S. R. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.24.17088 · Cited by 314
Activation of PPARδ alters lipid metabolism in db/db mice
Leibowitz, M. D., Fiévet, C., Hennuyer, N., Peinado-Onsurbe, J., Duez, H., Berger, J., Cullinan, C. A., Sparrow, C. P., Baffic, J., Berger, G. D., et al. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01554-4 · Cited by 308
Hormonal Signaling and Transcriptional Control of Adipocyte Differentiation
Morrison, R. F., & Farmer, S. R. (2000) · The Journal of Nutrition · doi:10.1093/jn/130.12.3116s · Cited by 307
Pioglitazone Induces In Vivo Adipocyte Differentiation in the Obese Zucker fa/fa Rat
Haliakon, S., Doaré, L., Foufelle, F., Kergoat, M., Guerre-Millo, M., Berthault, M.-F., Dugail, I., Morin, J., Auwerx, J., & Ferré, P. (1997) · Diabetes · doi:10.2337/diab.46.9.1393 · Cited by 306
Efficacy and Safety of Troglitazone in the Treatment of Lipodystrophy Syndromes
Arioglu, E., Duncan-Morin, J., Sebring, N., Rother, K. I., Gottlieb, N., Lieberman, J., Herion, D., Kleiner, D. E., Reynolds, J., Premkumar, A., et al. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-4-200008150-00009 · Cited by 303
Memon, R. A., Tecott, L. H., Nonogaki, K., Beigneux, A., Moser, A. H., Grunfeld, C., & Feingold, K. R. (2000) · Endocrinology · doi:10.1210/endo.141.11.7771 · Cited by 302
Beamer, B. A., Yen, C. J., Andersen, R. E., Muller, D., Elahi, D., Cheskin, L. J., Andres, R., Roth, J., & Shuldiner, A. R. (1998) · Diabetes · doi:10.2337/diabetes.47.11.1806 · Cited by 293
Werman, A., Hollenberg, A., Solanes, G., Bjørbæk, C., Vidal-Puig, A. J., & Flier, J. S. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.32.20230 · Cited by 282
Effect of troglitazone on body fat distribution in type 2 diabetic patients.
Mori, Y., Murakawa, Y., Okada, K., Horikoshi, H., Yokoyama, J., Tajima, N., & Ikeda, Y. (1999) · Diabetes Care · doi:10.2337/diacare.22.6.908 · Cited by 281
Miyazaki, Y., Glass, L., Triplitt, C., Matsuda, M., Cusi, K., Mahankali, A., Mahankali, S., Mandarino, L. J., & DeFronzo, R. A. (2001) · Diabetologia · doi:10.1007/s001250100031 · Cited by 274
The Pro12Ala Polymorphism in PPAR γ2 May Confer Resistance to Type 2 Diabetes
Hara, K., Okada, T., Tobe, K., Yasuda, K., Mori, Y., Kadowaki, H., Hagura, R., Akanuma, Y., Kimura, S., Ito, C., et al. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2605 · Cited by 273
A Unique PPARγ Ligand with Potent Insulin-Sensitizing yet Weak Adipogenic Activity
Rocchi, S., Picard, F., Vamecq, J., Gelman, L., Potier, N., Zeyer, D., Dubuquoy, L., Bac, P., Champy, M.-F., Plunket, K. D., et al. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00353-7 · Cited by 272
Gurnell, M., Wentworth, J. M., Agostini, M., Adams, M., Collingwood, T. N., Provenzano, C., Browne, P. O., Rajanayagam, O., Burris, T. P., Schwabe, J. W., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.8.5754 · Cited by 264
Dose-Response Effect of Pioglitazone on Insulin Sensitivity and Insulin Secretion in Type 2 Diabetes
Miyazaki, Y., Matsuda, M., & DeFronzo, R. A. (2002) · Diabetes Care · doi:10.2337/diacare.25.3.517 · Cited by 236
Young, P. W., Buckle, D. R., Cantello, B. C. C., Chapman, H., Clapham, J. C., Coyle, P. J., Haigh, D., Hindley, R. M., Holder, J. C., Kallender, H., et al. (1998) · PubMed · Cited by 229
Camp, H. S., Li, O., Wise, S. C., Hong, Y. H., Frankowski, C. L., Shen, X., Vanbogelen, R., & Leff, T. (2000) · Diabetes · doi:10.2337/diabetes.49.4.539 · Cited by 224
Masugi, J., Tamori, Y., Mori, H., Koike, T., & Kasuga, M. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2096 · Cited by 216
Regulation of Transcription by AMP-activated Protein Kinase
Yang, W., Hong, Y. H., Shen, X.-Q., Frankowski, C., Camp, H. S., & Leff, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c100316200 · Cited by 200
Ek, J., Urhammer, S. A., Sørensen, T. I. A., Andersen, T., Auwerx, J., & Pedersen, O. (1999) · Diabetologia · doi:10.1007/s001250051243 · Cited by 192
Iwamoto, Y., Kosaka, K., Kuzuya, T., Akanuma, Y., Shigeta, Y., & Kaneko, T. (1996) · Diabetes Care · doi:10.2337/diacare.19.2.151 · Cited by 179
Rosiglitazone in the treatment of type 2 diabetes mellitus: a critical review
Malinowski, J. M., & Bolesta, S. (2000) · Clinical Therapeutics · doi:10.1016/s0149-2918(00)83060-x · Cited by 177
Loviscach, M., Rehman, N., Carter, L., Mudaliar, S., Mohadeen, P., Ciaraldi, T. P., Veerkamp, J. H., & Henry, R. R. (2000) · Diabetologia · doi:10.1007/s001250050048 · Cited by 176
Hansen, J. B., Zhang, H., Rasmussen, T. H., Petersen, R. K., Flindt, E. N., & Kristiansen, K. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m005567200 · Cited by 173
Efficacy of troglitazone on body fat distribution in type 2 diabetes.
Akazawa, S., Sun, F., Ito, M., Kawasaki, E., & Eguchi, K. (2000) · Diabetes Care · doi:10.2337/diacare.23.8.1067 · Cited by 171
Bedoucha, M., Atzpodien, E., & Boelsterli, U. A. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00066-6 · Cited by 169
Chilcott, J. B., Tappenden, P., Jones, M. L., & Wight, J. (2001) · Clinical Therapeutics · doi:10.1016/s0149-2918(00)80078-8 · Cited by 162
Therapeutic index for rosiglitazone in dietary obese rats: separation of efficacy and haemodilution
Pickavance, L. C., Tadayyon, M., Widdowson, P. S., Buckingham, R. E., & Wilding, J. P. H. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702932 · Cited by 160
Rieusset, J., Andréelli, F., Auboeuf, D., Roques, M., Vallier, P., Riou, J. P., Auwerx, J. H., Laville, M., & Vidal, H. (1999) · Diabetes · doi:10.2337/diabetes.48.4.699 · Cited by 157
Mukherjee, R., Hoener, P. A., Jow, L., Bilakovics, J. M., Klausing, K., Mais, D. E., Faulkner, A. L., Croston, G. E., & Paterniti, J. R. (2000) · Molecular Endocrinology · doi:10.1210/mend.14.9.0528 · Cited by 157
Ek, J., Andersen, G., Urhammer, S. A., Hansen, L., Carstensen, B., Borch‐Johnsen, K., Drivsholm, T., Berglund, L., Hansen, T. K., Lithell, H., et al. (2001) · Diabetologia · doi:10.1007/s001250100629 · Cited by 150
Edvardsson, U., Bergström, M. F., Alexandersson, M., Bamberg, K., Ljung, B., & Dahllöf, B. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33479-9 · Cited by 139
Ibrahimi, A., Teboul, L., Gaillard, D., Amri, E., Ailhaud, G. P., Young, P. W., Cawthorne, M. A., & Grimaldi, P. A. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09853-0 · Cited by 137
Role of Skeletal Muscle in Thiazolidinedione Insulin Sensitizer (PPAR Agonist) Action
Zierath, J. R., Ryder, J. W., Doebber, T. W., Woods, J. W., Wu, M. S., Ventre, J. R., Li, Z., McCrary, C. T., Berger, J. P., Zhang, B., et al. (1998) · Endocrinology · doi:10.1210/endo.139.12.6364 · Cited by 136
Reduced insulin secretion: an independent predictor of body weight gain
Schwartz, M. W., Boyko, E. J., Kahn, S. E., Ravussin, É., & Bogardus, C. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.5.7745002 · Cited by 131
PPAR-gamma gene expression is elevated in skeletal muscle of obese and type II diabetic subjects
Park, K. S., Ciaraldi, T. P., Abrams-Carter, L., Mudaliar, S. R. D., Nikoulina, S. E., & Henry, R. R. (1997) · Diabetes · doi:10.2337/diab.46.7.1230 · Cited by 129
Troglitazone Reduces Plasma Leptin Concentration but Increases Hunger in NIDDM Patients
Shimizu, H., Tsuchiya, T., Sato, N., Shimomura, Y., Kobayashi, I., & Mori, M. (1998) · Diabetes Care · doi:10.2337/diacare.21.9.1470 · Cited by 115
Jiang, G., Dallas-Yang, Q., Li, Z., Szalkowski, D., Liu, F., Shen, X., Wu, M. S., Zhou, G., Doebber, T. W., Berger, J., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.8.2412 · Cited by 115
Lapsys, N. M., Kriketos, A. D., Lim-Fraser, M., Poynten, A. M., Lowy, A. J., Furler, S. M., Chisholm, D. J., & Cooney, G. J. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.11.6973 · Cited by 113
Nakamura, T., Funahashi, T., Yamashita, S., Nishida, M., Nishida, Y., Takahashi, M., Hotta, K., Kuriyama, H., Kihara, S., Ohuchi, N., et al. (2001) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(01)00319-9 · Cited by 104
Regional Differences in the Response of Human Pre-Adipocytes to PPARγ and RXRα Agonists
Sewter, C. P., Blows, F. M., Vidal‐Puig, A., & O’Rahilly, S. (2002) · Diabetes · doi:10.2337/diabetes.51.3.718 · Cited by 104
Nisoli, E., Carruba, M. O., Tonello, C., Macor, C., Federspil, G., & Vettor, R. (2000) · Diabetes · doi:10.2337/diabetes.49.3.319 · Cited by 101
Bastie, C. C., Luquet, S. H., Holst, D., Jehl-Piétri, C., & Grimaldi, P. A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006450200 · Cited by 98
Camp, H. S., Chaudhry, A., & Leff, T. (2001) · Endocrinology · doi:10.1210/endo.142.7.8254 · Cited by 95
Effects of troglitazone on fat distribution in the treatment of male type 2 diabetes
Kawai, T., Takei, I., Oguma, Y., Ohashi, N., Tokui, M., Oguchi, S., Katsukawa, F., Hirose, H., Shimada, A., Watanabe, K., et al. (1999) · Metabolism · doi:10.1016/s0026-0495(99)90122-1 · Cited by 93
Kruszynska, Y. T., Mukherjee, R., Jow, L., Dana, S. L., Paterniti, J. R., & Olefsky, J. M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1076 · Cited by 82
Hauner, H., Wabitsch, M., & Pfeiffer, E. F. (1988) · PubMed · Cited by 66
Metabolic effects of troglitazone therapy in type 2 diabetic, obese, and lean normal subjects.
Frías, J. P., Yu, J., Kruszynska, Y. T., & Olefsky, J. M. (2000) · Diabetes Care · doi:10.2337/diacare.23.1.64 · Cited by 61
Takamura, T., Nohara, E., Nagai, Y., & Kobayashi, K. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01053-6 · Cited by 60
PPARγ activators down‐regulate the expression of PPARγ in 3T3‐L1 adipocytes
Camp, H. S., Whitton, A. L., & Tafuri, S. R. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00268-9 · Cited by 57
Developmental and nutritional changes of ob and PPARγ2 gene expression in rat white adipose tissue
Rousseau, V., Becker, D., ONGEMBA, L. N., Rahier, J., Henquin, J., & Brichard, S. M. (1997) · Biochemical Journal · doi:10.1042/bj3210451 · Cited by 56
Differential Expression of PPAR γ1 and γ2 Isoforms in Human Adipose Tissue
Yanase, T., Yashiro, T., Takitani, K., Kato, S., Taniguchi, S., Takayanagi, R., & Nawata, H. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6446 · Cited by 50
Safety and tolerability of pioglitazone
Belcher, G., & Dr, M. (2000) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-2000-8529 · Cited by 41
Zinman, B. (2001) · Diabetes Obesity and Metabolism · doi:10.1046/j.1463-1326.2001.00033.x · Cited by 37
Vernochet, C., Milstone, D. S., Iehlé, C., Belmonte, N., Phillips, B. W., Wdziekonski, B., Villageois, P., Amri, E., O’Donnell, P., Mortensen, R. M., et al. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)03235-5 · Cited by 35
Shimaya, A., Kurosaki, E., Nakano, R., Hirayama, R., Shibasaki, M., & Shikama, H. (2000) · Metabolism · doi:10.1016/s0026-0495(00)90440-2 · Cited by 34
Hotta, K., Gustafson, T. A., Yoshioka, S., Ortmeyer, H. K., Bodkin, N. L., & Hansen, B. (1998) · International Journal of Obesity · doi:10.1038/sj.ijo.0800718 · Cited by 29
Hallakou, S., Foufelle, F., Doaré, L., Kergoat, M., & Ferré, P. (1998) · Diabetologia · doi:10.1007/s001250051014 · Cited by 26
Insulin‐sensitizing action of rosiglitazone is enhanced by preventing hyperphagia
Pickavance, L. C., Buckingham, R. E., & Wilding, J. P. H. (2001) · Diabetes Obesity and Metabolism · doi:10.1046/j.1463-1326.2001.00120.x · Cited by 26
Weight loss reduces expression of SREBP1c/ADD1 and PPARγ2 in adipose tissue of obese women
Ribot, J., Rantala, M., Kesäniemi, Y. A., Palou, A., & Savolainen, M. J. (2001) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s004240000454 · Cited by 20
Yakubu-Madus, F. E., Stephens, T. W., & Johnson, W. T. (2000) · Diabetes Obesity and Metabolism · doi:10.1046/j.1463-1326.2000.00075.x · Cited by 13
Cited by
Lamb, J., Crawford, E. D., Peck, D., Modell, J. W., Blat, I. C., Wrobel, M. J., Lerner, J., Brunet, J.-P., Subramanian, A., Ross, K. N., et al. (2006) · Science · doi:10.1126/science.1132939 · Cited by 5,257
Mechanisms of fatty acid-induced inhibition of glucose uptake.
Boden, G., Chen, X., Ruiz, J., White, J. V., & Rossetti, L. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117252 · Cited by 3,705
Transcriptional Regulation of Metabolism
Desvergne, B., Michalik, L., & Wahli, W. (2006) · Physiological Reviews · doi:10.1152/physrev.00025.2005 · Cited by 892
PPAR and human metabolic disease
Semple, R. K. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28003 · Cited by 827
The epidemiology of overweight and obesity: public health crisis or moral panic?
Campos, P., Saguy, A., Ernsberger, P., Oliver, E., & Gaesser, G. (2006) · International Journal of Epidemiology · doi:10.1093/ije/dyi254 · Cited by 744
Metadata
- Authors
- Larsen, T. M., Toubro, S., & Astrup, A.
- Venue
- International Journal of Obesity
- Published
- 2003-02
- Volume
- 27
- Issue
- 2
- Pages
- 147-161
- ISSN
- 0307-0565 (ISSN-L)
- 1476-5497
- OpenAlex
- W1979804924
- Cited by
- 282
- References
- 106
- FWCI
- 6.22
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.